Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125581924 | 12558192 | 4 | F | 2015 | 20160822 | 20160714 | 20160825 | EXP | CN-GLAXOSMITHKLINE-CN2016GSK099912 | GLAXOSMITHKLINE | 64.00 | YR | M | Y | 0.00000 | 20160825 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125581924 | 12558192 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | Y | X34X | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
| 125581924 | 12558192 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | Y | LD6G | 21077 | INHALATION POWDER | |||||||
| 125581924 | 12558192 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | Y | 0 | 1 | DF | BID | ||||||
| 125581924 | 12558192 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Y | 0 | |||||||||||
| 125581924 | 12558192 | 5 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | 0 | 1 | DF | QD | |||||||
| 125581924 | 12558192 | 6 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 125581924 | 12558192 | 7 | SS | Indacaterol | INDACATEROL | 1 | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125581924 | 12558192 | 1 | Emphysema |
| 125581924 | 12558192 | 2 | Chronic obstructive pulmonary disease |
| 125581924 | 12558192 | 3 | Emphysema |
| 125581924 | 12558192 | 4 | Chronic obstructive pulmonary disease |
| 125581924 | 12558192 | 5 | Emphysema |
| 125581924 | 12558192 | 6 | Chronic obstructive pulmonary disease |
| 125581924 | 12558192 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125581924 | 12558192 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125581924 | 12558192 | Bronchospasm | |
| 125581924 | 12558192 | Chronic obstructive pulmonary disease | |
| 125581924 | 12558192 | Disease recurrence | |
| 125581924 | 12558192 | Drug ineffective | |
| 125581924 | 12558192 | Nasopharyngitis | |
| 125581924 | 12558192 | Oxygen saturation decreased | |
| 125581924 | 12558192 | Product supply issue | |
| 125581924 | 12558192 | Suspected counterfeit product | |
| 125581924 | 12558192 | Weight decreased | |
| 125581924 | 12558192 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125581924 | 12558192 | 1 | 20160712 | 0 | ||
| 125581924 | 12558192 | 2 | 2016 | 0 | ||
| 125581924 | 12558192 | 3 | 2016 | 0 |